400
Participants
Start Date
November 6, 2020
Primary Completion Date
August 31, 2028
Study Completion Date
August 31, 2028
Early transition to oral antibiotics
Patients will be treated with an oral antibiotic regimen (e.g. amoxicillin + metronidazole) based upon pharmacokinetic and pharmacodynamic properties of the drugs, pathogen susceptibility, and any existing drug allergies or interactions
Standard treatment of intravenous antibiotics
Patients will continue standard intravenous antibiotic therapy for brain abscess (e.g. 3rd generation cephalosporin + metronidazole) according to international guidelines and pathogen susceptibility patterns.
RECRUITING
Aalborg University Hospital, Aalborg
RECRUITING
Aarhus University Hospital, Aarhus
RECRUITING
Rigshospitalet, Copenhagen
RECRUITING
Odense University Hospital, Odense
Henrik Nielsen
OTHER